Global Neurosurgery Drug Supply, Demand and Key Producers, 2023-2029

Description

The global Neurosurgery Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval.

This report studies the global Neurosurgery Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Neurosurgery Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurosurgery Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Neurosurgery Drug total production and demand, 2018-2029, (K Units)
Global Neurosurgery Drug total production value, 2018-2029, (USD Million)
Global Neurosurgery Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neurosurgery Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Neurosurgery Drug domestic production, consumption, key domestic manufacturers and share
Global Neurosurgery Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Neurosurgery Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neurosurgery Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Neurosurgery Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, AstraZeneca, Biogen, Jhonson & Jhonson, ABBVIE, Takeda Pharmaceuticals, UCB, IPSEN and Standigm, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neurosurgery Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Neurosurgery Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Neurosurgery Drug Market, Segmentation by Type
    Tablets
    Solution
    Capsules
    Others

Global Neurosurgery Drug Market, Segmentation by Application
    Hospital
    Clinic
    Others

Companies Profiled:
    Pfizer
    AstraZeneca
    Biogen
    Jhonson & Jhonson
    ABBVIE
    Takeda Pharmaceuticals
    UCB
    IPSEN
    Standigm
    BlueStar Genomic
    Tonix Pharmaceuticals
    BlackThorn Therapeutics
    Quentrix
    Wren Pharmaceuticals

Key Questions Answered
1. How big is the global Neurosurgery Drug market?
2. What is the demand of the global Neurosurgery Drug market?
3. What is the year over year growth of the global Neurosurgery Drug market?
4. What is the production and production value of the global Neurosurgery Drug market?
5. Who are the key producers in the global Neurosurgery Drug market?

Table of Contents

1 Supply Summary
    1.1 Neurosurgery Drug Introduction
    1.2 World Neurosurgery Drug Supply & Forecast
        1.2.1 World Neurosurgery Drug Production Value (2018 & 2022 & 2029)
        1.2.2 World Neurosurgery Drug Production (2018-2029)
        1.2.3 World Neurosurgery Drug Pricing Trends (2018-2029)
    1.3 World Neurosurgery Drug Production by Region (Based on Production Site)
        1.3.1 World Neurosurgery Drug Production Value by Region (2018-2029)
        1.3.2 World Neurosurgery Drug Production by Region (2018-2029)
        1.3.3 World Neurosurgery Drug Average Price by Region (2018-2029)
        1.3.4 North America Neurosurgery Drug Production (2018-2029)
        1.3.5 Europe Neurosurgery Drug Production (2018-2029)
        1.3.6 China Neurosurgery Drug Production (2018-2029)
        1.3.7 Japan Neurosurgery Drug Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Neurosurgery Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Neurosurgery Drug Major Market Trends

2 Demand Summary
    2.1 World Neurosurgery Drug Demand (2018-2029)
    2.2 World Neurosurgery Drug Consumption by Region
        2.2.1 World Neurosurgery Drug Consumption by Region (2018-2023)
        2.2.2 World Neurosurgery Drug Consumption Forecast by Region (2024-2029)
    2.3 United States Neurosurgery Drug Consumption (2018-2029)
    2.4 China Neurosurgery Drug Consumption (2018-2029)
    2.5 Europe Neurosurgery Drug Consumption (2018-2029)
    2.6 Japan Neurosurgery Drug Consumption (2018-2029)
    2.7 South Korea Neurosurgery Drug Consumption (2018-2029)
    2.8 ASEAN Neurosurgery Drug Consumption (2018-2029)
    2.9 India Neurosurgery Drug Consumption (2018-2029)

3 World Neurosurgery Drug Manufacturers Competitive Analysis
    3.1 World Neurosurgery Drug Production Value by Manufacturer (2018-2023)
    3.2 World Neurosurgery Drug Production by Manufacturer (2018-2023)
    3.3 World Neurosurgery Drug Average Price by Manufacturer (2018-2023)
    3.4 Neurosurgery Drug Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Neurosurgery Drug Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Neurosurgery Drug in 2022
        3.5.3 Global Concentration Ratios (CR8) for Neurosurgery Drug in 2022
    3.6 Neurosurgery Drug Market: Overall Company Footprint Analysis
        3.6.1 Neurosurgery Drug Market: Region Footprint
        3.6.2 Neurosurgery Drug Market: Company Product Type Footprint
        3.6.3 Neurosurgery Drug Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Neurosurgery Drug Production Value Comparison
        4.1.1 United States VS China: Neurosurgery Drug Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Neurosurgery Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Neurosurgery Drug Production Comparison
        4.2.1 United States VS China: Neurosurgery Drug Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Neurosurgery Drug Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Neurosurgery Drug Consumption Comparison
        4.3.1 United States VS China: Neurosurgery Drug Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Neurosurgery Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Neurosurgery Drug Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Neurosurgery Drug Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Neurosurgery Drug Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Neurosurgery Drug Production (2018-2023)
    4.5 China Based Neurosurgery Drug Manufacturers and Market Share
        4.5.1 China Based Neurosurgery Drug Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Neurosurgery Drug Production Value (2018-2023)
        4.5.3 China Based Manufacturers Neurosurgery Drug Production (2018-2023)
    4.6 Rest of World Based Neurosurgery Drug Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Neurosurgery Drug Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Neurosurgery Drug Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Neurosurgery Drug Production (2018-2023)

5 Market Analysis by Type
    5.1 World Neurosurgery Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Tablets
        5.2.2 Solution
        5.2.3 Capsules
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Neurosurgery Drug Production by Type (2018-2029)
        5.3.2 World Neurosurgery Drug Production Value by Type (2018-2029)
        5.3.3 World Neurosurgery Drug Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Neurosurgery Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Neurosurgery Drug Production by Application (2018-2029)
        6.3.2 World Neurosurgery Drug Production Value by Application (2018-2029)
        6.3.3 World Neurosurgery Drug Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer Neurosurgery Drug Product and Services
        7.1.4 Pfizer Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 AstraZeneca
        7.2.1 AstraZeneca Details
        7.2.2 AstraZeneca Major Business
        7.2.3 AstraZeneca Neurosurgery Drug Product and Services
        7.2.4 AstraZeneca Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 AstraZeneca Recent Developments/Updates
        7.2.6 AstraZeneca Competitive Strengths & Weaknesses
    7.3 Biogen
        7.3.1 Biogen Details
        7.3.2 Biogen Major Business
        7.3.3 Biogen Neurosurgery Drug Product and Services
        7.3.4 Biogen Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Biogen Recent Developments/Updates
        7.3.6 Biogen Competitive Strengths & Weaknesses
    7.4 Jhonson & Jhonson
        7.4.1 Jhonson & Jhonson Details
        7.4.2 Jhonson & Jhonson Major Business
        7.4.3 Jhonson & Jhonson Neurosurgery Drug Product and Services
        7.4.4 Jhonson & Jhonson Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Jhonson & Jhonson Recent Developments/Updates
        7.4.6 Jhonson & Jhonson Competitive Strengths & Weaknesses
    7.5 ABBVIE
        7.5.1 ABBVIE Details
        7.5.2 ABBVIE Major Business
        7.5.3 ABBVIE Neurosurgery Drug Product and Services
        7.5.4 ABBVIE Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 ABBVIE Recent Developments/Updates
        7.5.6 ABBVIE Competitive Strengths & Weaknesses
    7.6 Takeda Pharmaceuticals
        7.6.1 Takeda Pharmaceuticals Details
        7.6.2 Takeda Pharmaceuticals Major Business
        7.6.3 Takeda Pharmaceuticals Neurosurgery Drug Product and Services
        7.6.4 Takeda Pharmaceuticals Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Takeda Pharmaceuticals Recent Developments/Updates
        7.6.6 Takeda Pharmaceuticals Competitive Strengths & Weaknesses
    7.7 UCB
        7.7.1 UCB Details
        7.7.2 UCB Major Business
        7.7.3 UCB Neurosurgery Drug Product and Services
        7.7.4 UCB Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 UCB Recent Developments/Updates
        7.7.6 UCB Competitive Strengths & Weaknesses
    7.8 IPSEN
        7.8.1 IPSEN Details
        7.8.2 IPSEN Major Business
        7.8.3 IPSEN Neurosurgery Drug Product and Services
        7.8.4 IPSEN Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 IPSEN Recent Developments/Updates
        7.8.6 IPSEN Competitive Strengths & Weaknesses
    7.9 Standigm
        7.9.1 Standigm Details
        7.9.2 Standigm Major Business
        7.9.3 Standigm Neurosurgery Drug Product and Services
        7.9.4 Standigm Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Standigm Recent Developments/Updates
        7.9.6 Standigm Competitive Strengths & Weaknesses
    7.10 BlueStar Genomic
        7.10.1 BlueStar Genomic Details
        7.10.2 BlueStar Genomic Major Business
        7.10.3 BlueStar Genomic Neurosurgery Drug Product and Services
        7.10.4 BlueStar Genomic Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 BlueStar Genomic Recent Developments/Updates
        7.10.6 BlueStar Genomic Competitive Strengths & Weaknesses
    7.11 Tonix Pharmaceuticals
        7.11.1 Tonix Pharmaceuticals Details
        7.11.2 Tonix Pharmaceuticals Major Business
        7.11.3 Tonix Pharmaceuticals Neurosurgery Drug Product and Services
        7.11.4 Tonix Pharmaceuticals Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Tonix Pharmaceuticals Recent Developments/Updates
        7.11.6 Tonix Pharmaceuticals Competitive Strengths & Weaknesses
    7.12 BlackThorn Therapeutics
        7.12.1 BlackThorn Therapeutics Details
        7.12.2 BlackThorn Therapeutics Major Business
        7.12.3 BlackThorn Therapeutics Neurosurgery Drug Product and Services
        7.12.4 BlackThorn Therapeutics Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 BlackThorn Therapeutics Recent Developments/Updates
        7.12.6 BlackThorn Therapeutics Competitive Strengths & Weaknesses
    7.13 Quentrix
        7.13.1 Quentrix Details
        7.13.2 Quentrix Major Business
        7.13.3 Quentrix Neurosurgery Drug Product and Services
        7.13.4 Quentrix Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Quentrix Recent Developments/Updates
        7.13.6 Quentrix Competitive Strengths & Weaknesses
    7.14 Wren Pharmaceuticals
        7.14.1 Wren Pharmaceuticals Details
        7.14.2 Wren Pharmaceuticals Major Business
        7.14.3 Wren Pharmaceuticals Neurosurgery Drug Product and Services
        7.14.4 Wren Pharmaceuticals Neurosurgery Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Wren Pharmaceuticals Recent Developments/Updates
        7.14.6 Wren Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Neurosurgery Drug Industry Chain
    8.2 Neurosurgery Drug Upstream Analysis
        8.2.1 Neurosurgery Drug Core Raw Materials
        8.2.2 Main Manufacturers of Neurosurgery Drug Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Neurosurgery Drug Production Mode
    8.6 Neurosurgery Drug Procurement Model
    8.7 Neurosurgery Drug Industry Sales Model and Sales Channels
        8.7.1 Neurosurgery Drug Sales Model
        8.7.2 Neurosurgery Drug Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Neurosurgery Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Neurosurgery Drug Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Neurosurgery Drug Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Neurosurgery Drug Production Value Market Share by Region (2018-2023)
    Table 5. World Neurosurgery Drug Production Value Market Share by Region (2024-2029)
    Table 6. World Neurosurgery Drug Production by Region (2018-2023) & (K Units)
    Table 7. World Neurosurgery Drug Production by Region (2024-2029) & (K Units)
    Table 8. World Neurosurgery Drug Production Market Share by Region (2018-2023)
    Table 9. World Neurosurgery Drug Production Market Share by Region (2024-2029)
    Table 10. World Neurosurgery Drug Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Neurosurgery Drug Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Neurosurgery Drug Major Market Trends
    Table 13. World Neurosurgery Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Neurosurgery Drug Consumption by Region (2018-2023) & (K Units)
    Table 15. World Neurosurgery Drug Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Neurosurgery Drug Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Neurosurgery Drug Producers in 2022
    Table 18. World Neurosurgery Drug Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Neurosurgery Drug Producers in 2022
    Table 20. World Neurosurgery Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Neurosurgery Drug Company Evaluation Quadrant
    Table 22. World Neurosurgery Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Neurosurgery Drug Production Site of Key Manufacturer
    Table 24. Neurosurgery Drug Market: Company Product Type Footprint
    Table 25. Neurosurgery Drug Market: Company Product Application Footprint
    Table 26. Neurosurgery Drug Competitive Factors
    Table 27. Neurosurgery Drug New Entrant and Capacity Expansion Plans
    Table 28. Neurosurgery Drug Mergers & Acquisitions Activity
    Table 29. United States VS China Neurosurgery Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Neurosurgery Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Neurosurgery Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Neurosurgery Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Neurosurgery Drug Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Neurosurgery Drug Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Neurosurgery Drug Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Neurosurgery Drug Production Market Share (2018-2023)
    Table 37. China Based Neurosurgery Drug Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Neurosurgery Drug Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Neurosurgery Drug Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Neurosurgery Drug Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Neurosurgery Drug Production Market Share (2018-2023)
    Table 42. Rest of World Based Neurosurgery Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Neurosurgery Drug Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Neurosurgery Drug Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Neurosurgery Drug Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Neurosurgery Drug Production Market Share (2018-2023)
    Table 47. World Neurosurgery Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Neurosurgery Drug Production by Type (2018-2023) & (K Units)
    Table 49. World Neurosurgery Drug Production by Type (2024-2029) & (K Units)
    Table 50. World Neurosurgery Drug Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Neurosurgery Drug Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Neurosurgery Drug Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Neurosurgery Drug Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Neurosurgery Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Neurosurgery Drug Production by Application (2018-2023) & (K Units)
    Table 56. World Neurosurgery Drug Production by Application (2024-2029) & (K Units)
    Table 57. World Neurosurgery Drug Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Neurosurgery Drug Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Neurosurgery Drug Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Neurosurgery Drug Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 62. Pfizer Major Business
    Table 63. Pfizer Neurosurgery Drug Product and Services
    Table 64. Pfizer Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Pfizer Recent Developments/Updates
    Table 66. Pfizer Competitive Strengths & Weaknesses
    Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 68. AstraZeneca Major Business
    Table 69. AstraZeneca Neurosurgery Drug Product and Services
    Table 70. AstraZeneca Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. AstraZeneca Recent Developments/Updates
    Table 72. AstraZeneca Competitive Strengths & Weaknesses
    Table 73. Biogen Basic Information, Manufacturing Base and Competitors
    Table 74. Biogen Major Business
    Table 75. Biogen Neurosurgery Drug Product and Services
    Table 76. Biogen Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Biogen Recent Developments/Updates
    Table 78. Biogen Competitive Strengths & Weaknesses
    Table 79. Jhonson & Jhonson Basic Information, Manufacturing Base and Competitors
    Table 80. Jhonson & Jhonson Major Business
    Table 81. Jhonson & Jhonson Neurosurgery Drug Product and Services
    Table 82. Jhonson & Jhonson Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Jhonson & Jhonson Recent Developments/Updates
    Table 84. Jhonson & Jhonson Competitive Strengths & Weaknesses
    Table 85. ABBVIE Basic Information, Manufacturing Base and Competitors
    Table 86. ABBVIE Major Business
    Table 87. ABBVIE Neurosurgery Drug Product and Services
    Table 88. ABBVIE Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. ABBVIE Recent Developments/Updates
    Table 90. ABBVIE Competitive Strengths & Weaknesses
    Table 91. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 92. Takeda Pharmaceuticals Major Business
    Table 93. Takeda Pharmaceuticals Neurosurgery Drug Product and Services
    Table 94. Takeda Pharmaceuticals Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Takeda Pharmaceuticals Recent Developments/Updates
    Table 96. Takeda Pharmaceuticals Competitive Strengths & Weaknesses
    Table 97. UCB Basic Information, Manufacturing Base and Competitors
    Table 98. UCB Major Business
    Table 99. UCB Neurosurgery Drug Product and Services
    Table 100. UCB Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. UCB Recent Developments/Updates
    Table 102. UCB Competitive Strengths & Weaknesses
    Table 103. IPSEN Basic Information, Manufacturing Base and Competitors
    Table 104. IPSEN Major Business
    Table 105. IPSEN Neurosurgery Drug Product and Services
    Table 106. IPSEN Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. IPSEN Recent Developments/Updates
    Table 108. IPSEN Competitive Strengths & Weaknesses
    Table 109. Standigm Basic Information, Manufacturing Base and Competitors
    Table 110. Standigm Major Business
    Table 111. Standigm Neurosurgery Drug Product and Services
    Table 112. Standigm Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Standigm Recent Developments/Updates
    Table 114. Standigm Competitive Strengths & Weaknesses
    Table 115. BlueStar Genomic Basic Information, Manufacturing Base and Competitors
    Table 116. BlueStar Genomic Major Business
    Table 117. BlueStar Genomic Neurosurgery Drug Product and Services
    Table 118. BlueStar Genomic Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. BlueStar Genomic Recent Developments/Updates
    Table 120. BlueStar Genomic Competitive Strengths & Weaknesses
    Table 121. Tonix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 122. Tonix Pharmaceuticals Major Business
    Table 123. Tonix Pharmaceuticals Neurosurgery Drug Product and Services
    Table 124. Tonix Pharmaceuticals Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Tonix Pharmaceuticals Recent Developments/Updates
    Table 126. Tonix Pharmaceuticals Competitive Strengths & Weaknesses
    Table 127. BlackThorn Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 128. BlackThorn Therapeutics Major Business
    Table 129. BlackThorn Therapeutics Neurosurgery Drug Product and Services
    Table 130. BlackThorn Therapeutics Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. BlackThorn Therapeutics Recent Developments/Updates
    Table 132. BlackThorn Therapeutics Competitive Strengths & Weaknesses
    Table 133. Quentrix Basic Information, Manufacturing Base and Competitors
    Table 134. Quentrix Major Business
    Table 135. Quentrix Neurosurgery Drug Product and Services
    Table 136. Quentrix Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Quentrix Recent Developments/Updates
    Table 138. Wren Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 139. Wren Pharmaceuticals Major Business
    Table 140. Wren Pharmaceuticals Neurosurgery Drug Product and Services
    Table 141. Wren Pharmaceuticals Neurosurgery Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 142. Global Key Players of Neurosurgery Drug Upstream (Raw Materials)
    Table 143. Neurosurgery Drug Typical Customers
    Table 144. Neurosurgery Drug Typical Distributors
List of Figure
    Figure 1. Neurosurgery Drug Picture
    Figure 2. World Neurosurgery Drug Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Neurosurgery Drug Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Neurosurgery Drug Production (2018-2029) & (K Units)
    Figure 5. World Neurosurgery Drug Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Neurosurgery Drug Production Value Market Share by Region (2018-2029)
    Figure 7. World Neurosurgery Drug Production Market Share by Region (2018-2029)
    Figure 8. North America Neurosurgery Drug Production (2018-2029) & (K Units)
    Figure 9. Europe Neurosurgery Drug Production (2018-2029) & (K Units)
    Figure 10. China Neurosurgery Drug Production (2018-2029) & (K Units)
    Figure 11. Japan Neurosurgery Drug Production (2018-2029) & (K Units)
    Figure 12. Neurosurgery Drug Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Neurosurgery Drug Consumption (2018-2029) & (K Units)
    Figure 15. World Neurosurgery Drug Consumption Market Share by Region (2018-2029)
    Figure 16. United States Neurosurgery Drug Consumption (2018-2029) & (K Units)
    Figure 17. China Neurosurgery Drug Consumption (2018-2029) & (K Units)
    Figure 18. Europe Neurosurgery Drug Consumption (2018-2029) & (K Units)
    Figure 19. Japan Neurosurgery Drug Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Neurosurgery Drug Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Neurosurgery Drug Consumption (2018-2029) & (K Units)
    Figure 22. India Neurosurgery Drug Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Neurosurgery Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Neurosurgery Drug Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Neurosurgery Drug Markets in 2022
    Figure 26. United States VS China: Neurosurgery Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Neurosurgery Drug Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Neurosurgery Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Neurosurgery Drug Production Market Share 2022
    Figure 30. China Based Manufacturers Neurosurgery Drug Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Neurosurgery Drug Production Market Share 2022
    Figure 32. World Neurosurgery Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Neurosurgery Drug Production Value Market Share by Type in 2022
    Figure 34. Tablets
    Figure 35. Solution
    Figure 36. Capsules
    Figure 37. Others
    Figure 38. World Neurosurgery Drug Production Market Share by Type (2018-2029)
    Figure 39. World Neurosurgery Drug Production Value Market Share by Type (2018-2029)
    Figure 40. World Neurosurgery Drug Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Neurosurgery Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Neurosurgery Drug Production Value Market Share by Application in 2022
    Figure 43. Hospital
    Figure 44. Clinic
    Figure 45. Others
    Figure 46. World Neurosurgery Drug Production Market Share by Application (2018-2029)
    Figure 47. World Neurosurgery Drug Production Value Market Share by Application (2018-2029)
    Figure 48. World Neurosurgery Drug Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Neurosurgery Drug Industry Chain
    Figure 50. Neurosurgery Drug Procurement Model
    Figure 51. Neurosurgery Drug Sales Model
    Figure 52. Neurosurgery Drug Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Companies Mentioned

Pfizer
AstraZeneca
Biogen
Jhonson & Jhonson
ABBVIE
Takeda Pharmaceuticals
UCB
IPSEN
Standigm
BlueStar Genomic
Tonix Pharmaceuticals
BlackThorn Therapeutics
Quentrix
Wren Pharmaceuticals